21ьз╕ C

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

News Provided by PR Newswire2025-07-17

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

[17-July-2025]

QuidelOrtho Announces Featured ADLM Session

SAN DIEGO, July 17, 2025 /PRNewswire/ -- How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

ADLM Session Details:

Session Title:	Real Labs, Real Decisions with Actionable Six Sigma Metrics
When:	Tuesday, July 29, 2025
Where:	McCormick Convention Center Chicago, IL Exhibit Hall, Theater 1
Time:	2:45 p.m. – 3:45 p.m. CT
Registration:	Space is limited. ADLM attendees can register for the session using this link: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe Media registered for ADLM – please reach out to Nikki Wheeler to access the session at Nikki.Wheeler@QuidelOrtho.com
Registration:

Real Labs, Real Decisions With Actionable Six Sigma Metrics Panelists:

Dr. Jared Jaeger
Clinical Science Liaison
QuidelOrtho
Moderator

Dr. Bremansu Osa-Andrews
Medical Director of Clinical
Chemistry and Clinical Assistant Professor
University of Florida PathLab

Gilles Attipoe
Director of Laboratory Services
St. Peter's University Hospital

Angela Armato
Core Lab Manager
United Health Services and UHS Hospitals

To learn more about Six Sigma and the value of using real-world data listen to "Sigma Metrics and the Value of Real World Evidence." In this podcast, QuidelOrtho data scientist Johanna Miller discusses how Six Sigma metrics are being adapted for the clinical laboratory.

Unable to attend ADLM? Register to watch a recording of the session: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe.

About QuidelOrtho
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed–from home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.

Investor Contact:

Juliet Cunningham

Vice President, Investor Relations

IR@QuidelOrtho.com

Media Contact:

D. Nikki Wheeler

Senior Director, Corporate Communications

Media@QuidelOrtho.com